A case of an early-relapsed high-risk T-ALL with high BCL-2 expression on leukemic blasts was successfully treated with decitabine and venetoclax, achieving a CR. We suggest decitabine and venetoclax should be synergistic in BCL2-positive ALL.

Zappone, E., Cencini, E., Defina, M., Sicuranza, A., Gozzetti, A., Ciofini, S., et al. (2020). Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia. CLINICAL CASE REPORTS, 8(10), 2000-2002 [10.1002/ccr3.3041].

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia

Sicuranza A.;Gozzetti A.;Bocchia M.
2020-01-01

Abstract

A case of an early-relapsed high-risk T-ALL with high BCL-2 expression on leukemic blasts was successfully treated with decitabine and venetoclax, achieving a CR. We suggest decitabine and venetoclax should be synergistic in BCL2-positive ALL.
2020
Zappone, E., Cencini, E., Defina, M., Sicuranza, A., Gozzetti, A., Ciofini, S., et al. (2020). Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia. CLINICAL CASE REPORTS, 8(10), 2000-2002 [10.1002/ccr3.3041].
File in questo prodotto:
File Dimensione Formato  
venetoclax.pdf

accesso aperto

Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 218.36 kB
Formato Adobe PDF
218.36 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1115022